Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

CapsoVision, Inc.

CVNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Sep 23, 2026Accepted Sep 23, 2026, 9:01 PM EDTFiling CIK 1378325Accession 0001009165-26-000009
Share

Structured filing — 4

primary_doc.xml

Open full document ↗

Filing details

Report period
2026-09-18
Issuer
CapsoVision, Inc
Issuer CIK
0001378325
Trading symbol
CV

Reporting owner 1

Name
HARARI ELIYAHOU ET AL
Reporting owner CIK
0001009165
Relationship
10% owner
Address
2290 NORTH 1ST STREET, SUITE 102, SAN JOSE, CA, 95131

Non-derivative transactions

Non-derivative transactions · 2 reported rows
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnershipNature of ownership
Common Stock2026-09-18P · Form 4878,735A5.691,396,494IBy trust.[F1]
Common Stock2026-09-18P · Form 4878,734A5.69878,734IBy trust.[F2]
Table key
P · Form 4
Purchase on the market or privately
A
Acquired
I
Indirect

Footnotes

F1
The securities are held by The Harari 2010 Children Remainder Trust - DAH, for which the Reporting Person, together with his wife, are trustees.↩ 1
F2
The securities are held by The Harari Descendant's Trust-2012, for which the Reporting Person, together with his wife, are trustees.↩ 1

Signature 1

Signed
/s/ Peter Bergman, Attorney-in-Fact for Eliyahou Harari
Date
2026-09-23

Company context

We are a global commercial-stage medical technology company focused on creating diagnostic and screening products to identify abnormalities of the GI tract. We develop advanced imaging and AI technologies in creating such products while maximizing the flexibility, convenience, profitability, and safety of patient care. We are a Delaware company, incorporated in 2005. Our corporate headquarters is located in Saratoga, California.

Current securities

Recent company filings

  1. 10-Q filingNov 12, 2026
  2. Results of Operations and Financial ConditionNov 12, 2026
  3. SCHEDULE 13G/A - filed by HARARI ELIYAHOU ET AL regarding CapsoVision, IncNov 4, 2026
  4. Other EventsSep 28, 2026
  5. Entry into a Material Definitive AgreementSep 18, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.